diaDexus, Inc. to Host Conference Call and Webcast March 7, 2013 to Discuss
Fourth Quarter and Full Year 2012 Financial Results
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2013 (GLOBE NEWSWIRE) -- diaDexus, Inc.
(OTCQB:DDXS), a company developing and commercializing proprietary
cardiovascular diagnostic products, today announced that it will host a
conference call and webcast on Thursday, March 7, 2013 at 4:30 PM ET (1:30 PM
PT) to discuss its 2012 fourth quarter and full year results.
The dial-in numbers for the conference call are 1 (877) 378-9048 for domestic
callers and 1 (706) 679-2272 for international. The reservation number for
both is 98712962. The webcast may be accessed via the company's website at
www.diadexus.com/webcast. A replay of the webcast will be available shortly
following the live webcast.
About diaDexus, Inc.
diaDexus, Inc., based in South San Francisco, California, develops and
commercializes proprietary cardiovascular diagnostic products addressing unmet
needs in cardiovascular disease. The company's PLAC® Test ELISA Kit is the
only blood test cleared by the FDA to aid in predicting risk for both coronary
heart disease and ischemic stroke associated with atherosclerosis, the #1 and
#3 causes of death, respectively, in the United States. The company's PLAC®
Test for Lp-PLA Activity, a CE-marked test, is an indicator of
atherosclerotic cardiovascular disease, the #1 cause of death in Europe.
diaDexus is ISO 13485 certified and is manufacturing the PLAC Test for
Lp-PLA Activity on-site. For more information, please visit the company's
website at www.diaDexus.com.
CONTACT: Company Contacts:
Brian E. Ward, Ph.D., CEO
Jean-Frederic Viret, Ph.D., CFO
The Ruth Group
Press spacebar to pause and continue. Press esc to stop.